You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 7, 2025

Patent: 10,130,697


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,130,697
Title:Vaccines comprising mutant attenuated influenza viruses
Abstract: The invention provides a vaccine comprising an effective amount of an isolated recombinant influenza virus comprising a mutant M gene segment that is mutated so that upon viral replication the mutant M gene expresses a functional M1 protein and a mutant M2 protein with a deletion of the cytoplasmic tail and either lacking a transmembrane domain or having a mutated transmembrane domain.
Inventor(s): Watanabe; Shinji (Madison, WI), Watanabe; Tokiko (Madison, WI), Kawaoka; Yoshihiro (Middleton, WI)
Assignee: Wisconsin Alumni Research Foundation (WARF) (Madison, WI)
Application Number:13/070,110
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Comprehensive and Critical Analysis of the Claims and Patent Landscape for United States Patent 10,130,697

Introduction

Understanding the nuances of patent law and the specific claims of a patent is crucial for innovators, patent practitioners, and businesses seeking to protect and leverage their intellectual property. This analysis will delve into the key aspects of United States Patent 10,130,697, focusing on the determination of inventorship, the obviousness standard, and the broader patent landscape.

Determining Inventorship

Inventorship is a critical component of patent law, as it determines who is entitled to a patent. According to U.S. patent law, the "true and only" inventors must be listed in the patent application. The conception step is paramount in determining inventorship, which involves the formation of a definite and permanent idea of the complete and operative invention[1].

Conception vs. Reduction to Practice

  • Conception: This is the mental process of forming a definite and permanent idea of the invention. It must include every feature of the subject matter claimed in the patent.
  • Reduction to Practice: This involves turning the conceived idea into a physical reality. However, merely reducing an invention to practice by exercising ordinary skill in the art does not qualify someone as an inventor[1].

Collaborative Efforts

Inventorship can also be attributed to two or more persons who collaborate to produce the invention through aggregate efforts. However, contributors who only assist in the reduction to practice or perform routine experiments are not considered inventors[1].

The Obviousness Standard

The obviousness standard, as outlined in Section 103(a) of the US Patent Act, is a critical factor in determining the patentability of an invention. This standard ensures that an invention is not obvious to a person having ordinary skill in the art (PHOSITA).

Graham Factors

The Supreme Court in the case of Graham v. John Deere established a test for assessing patentability under Section 103(a). This involves:

  • Determining the scope and content of the prior art.
  • Ascertaining the differences between the prior art and the claims at issue.
  • Resolving the level of ordinary skill in the pertinent art.
  • Determining the obviousness or non-obviousness of the subject matter based on these factors[2].

Teaching, Suggestion, and Motivation (TSM) Test

The TSM test is used to evaluate whether the prior art suggested the combination of known elements in a way that would have been obvious to a PHOSITA. This test helps offset hindsight bias by ensuring the analysis is based on the resources available at the time of the invention, not when the patent is granted[2].

Patent Claims Analysis

Claim Structure and Scope

Patent claims define the scope of the invention and are crucial for determining what is protected by the patent. Each claim must be carefully crafted to ensure it covers the inventive concept without being overly broad or vague.

Practical Application and Real-World Benefits

Recent USPTO guidance emphasizes the importance of demonstrating how an abstract idea is applied in a practical manner to improve technology or solve specific problems. Claims that merely use abstract ideas without a practical application are more likely to face section 101 rejections[5].

Patent Landscape and Trends

AI and Software-Related Patents

The 2024 USPTO guidance update on AI patents highlights the need for clear and practical applications of AI technology to ensure patent eligibility. This update is particularly relevant for patents like 10,130,697, which may involve complex software or AI components[5].

Fuel Cell and Hydrogen Technologies

While not directly related to AI, the patent landscape in fields like fuel cells and hydrogen production shows a significant increase in patent filings over the years. This trend indicates a growing interest in innovative technologies and the importance of robust patent protection in these areas[4].

Case Law and Precedents

Court of Appeals for the Federal Circuit

The Court of Appeals for the Federal Circuit plays a crucial role in interpreting patent law and resolving disputes. Decisions from this court, such as those related to inventorship and obviousness, set important precedents that guide patent practitioners and innovators[1][2].

Chisum on Patents

Donald S. Chisum's treatise on patents is a seminal work that provides authoritative analysis on all aspects of patent law, including doctrines, rules, and case law. It is a valuable resource for understanding the complexities of patent claims and the broader patent landscape[3].

Key Takeaways

  • Inventorship: Accurate determination of inventorship is crucial, focusing on the conception step and excluding those who only contribute to the reduction to practice.
  • Obviousness Standard: The Graham factors and TSM test are essential for evaluating the patentability of an invention, ensuring it is not obvious to a PHOSITA.
  • Practical Application: Claims must demonstrate a practical application of the inventive concept to avoid section 101 rejections.
  • Patent Landscape: The patent landscape is evolving, with specific guidance updates for AI and software-related patents, and a growing trend in innovative technologies like fuel cells and hydrogen production.

FAQs

What is the significance of the conception step in determining inventorship?

The conception step is critical because it involves the formation of a definite and permanent idea of the complete and operative invention. Only those who contribute to this mental process are considered inventors[1].

How does the Graham v. John Deere case impact the obviousness standard?

The Graham v. John Deere case established a test for assessing patentability under Section 103(a), which includes determining the scope and content of the prior art, ascertaining differences between the prior art and the claims, and resolving the level of ordinary skill in the pertinent art[2].

What is the TSM test, and how is it used in patent analysis?

The TSM test evaluates whether the prior art suggested the combination of known elements in a way that would have been obvious to a PHOSITA. It helps offset hindsight bias by focusing on resources available at the time of the invention[2].

How does the 2024 USPTO guidance update affect AI-related patents?

The update provides examples of patent-eligible and ineligible claims directed to AI technology, emphasizing the need for practical applications and concrete benefits to ensure patent eligibility[5].

What is the importance of Chisum on Patents in understanding patent law?

Chisum on Patents is a comprehensive treatise that provides authoritative analysis on all aspects of patent law, including doctrines, rules, and case law, making it a valuable resource for patent practitioners and innovators[3].

Sources Cited

  1. Determining Inventorship for US Patent Applications - Oregon State University
  2. AN ANALYSIS OF OBVIOUSNESS STANDARD IN PATENT LAW - USPTO
  3. Chisum on Patents - LexisNexis Store
  4. hfto-2021-patent-analysis.pdf - Department of Energy
  5. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz Insights Center

More… ↓

⤷  Subscribe

Details for Patent 10,130,697

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.